Clinical Trial

XORTX Initiates Precision Medicine Program

Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine MetabolismCALGARY, Alberta, Oct.…

1 year ago

BioCorteX Unveils Critical Bacteria Interactions in ADC Cancer Treatment, Enabled by Google Cloud

LONDON, Oct. 9, 2024 /PRNewswire/ -- BioCorteX, a leading biotech innovator, today formally announced a breakthrough in the field of Antibody-Drug…

1 year ago

AWAK Transforms into Vivance, Unveiling a New Brand Identity

SINGAPORE, Oct. 9, 2024 /PRNewswire/ -- AWAK Technologies, a pioneer in innovative kidney care is excited to announce its rebranding…

1 year ago

Dermata Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit on Tuesday, October 15, 2024

SAN DIEGO, CA / ACCESSWIRE / October 8, 2024 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata" or the "Company"), a late-stage…

1 year ago

WCG Releases 2024 Report on Top Issues Impacting Clinical Research Sites

PRINCETON, N.J., Oct. 8, 2024 /PRNewswire/ -- WCG, the global leader in providing solutions that measurably improve the quality and…

1 year ago

UFC’s Michael Chandler Joins “Official UFC Partner” Aires Tech To Champion EMF Protection As Brand Partner

Chandler strengthens the #AiresAthletes campaign, reinforcing the importance of EMF protection to enhance recovery and overall well-being*Chandler fuels Aires' brand…

1 year ago

Florence Healthcare Partners with ScienceMedia to Ease Training Burden for Clinical Sites

SAN DIEGO, Oct. 8, 2024 /PRNewswire/ -- ScienceMedia, a global SaaS clinical trial training solution provider, and Florence Healthcare, the…

1 year ago

NanoViricides to Present at the Global AMR Summit 2024 Tomorrow

Dr. Diwan to Discuss "Shape-Shifting", "Trojan Horse", Pathogen-Directed Attack Capability of NanoViricides Platform Technology to Combat AMR SHELTON, CT /…

1 year ago

PharmAla to supply the University of Texas, San Antonio, with novel dosage form of LaNeo™ MDMA

TORONTO, Oct. 08, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a…

1 year ago